PANI, Luca
 Distribuzione geografica
Continente #
NA - Nord America 9.612
EU - Europa 2.587
AS - Asia 1.306
SA - Sud America 28
AF - Africa 25
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 13.586
Nazione #
US - Stati Uniti d'America 9.572
GB - Regno Unito 749
IT - Italia 651
HK - Hong Kong 422
SE - Svezia 414
SG - Singapore 311
CN - Cina 269
BG - Bulgaria 195
DE - Germania 124
FI - Finlandia 90
IE - Irlanda 70
TR - Turchia 59
ID - Indonesia 56
FR - Francia 35
IN - India 31
MY - Malesia 31
CA - Canada 30
JP - Giappone 27
LT - Lituania 27
ES - Italia 25
UA - Ucraina 23
CH - Svizzera 21
NL - Olanda 21
BE - Belgio 17
VN - Vietnam 17
KH - Cambogia 16
TW - Taiwan 16
AU - Australia 15
AT - Austria 14
BR - Brasile 13
CZ - Repubblica Ceca 13
ZA - Sudafrica 13
KR - Corea 12
EU - Europa 11
RS - Serbia 11
HU - Ungheria 9
RO - Romania 9
RU - Federazione Russa 8
GR - Grecia 7
HR - Croazia 7
IL - Israele 7
IR - Iran 7
AR - Argentina 6
PL - Polonia 6
LU - Lussemburgo 5
NO - Norvegia 5
PH - Filippine 5
CO - Colombia 4
DK - Danimarca 4
DZ - Algeria 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
BN - Brunei Darussalam 3
CL - Cile 3
EE - Estonia 3
EG - Egitto 3
MD - Moldavia 3
MK - Macedonia 3
NG - Nigeria 3
PA - Panama 3
SA - Arabia Saudita 3
TH - Thailandia 3
AL - Albania 2
CR - Costa Rica 2
LK - Sri Lanka 2
ME - Montenegro 2
MX - Messico 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BT - Bhutan 1
EC - Ecuador 1
GH - Ghana 1
GT - Guatemala 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MA - Marocco 1
MC - Monaco 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
SI - Slovenia 1
Totale 13.586
Città #
Fairfield 1.775
Chandler 1.099
Woodbridge 793
Ashburn 743
Houston 666
Seattle 598
Wilmington 578
Cambridge 539
Southend 450
Hong Kong 419
Nyköping 356
Ann Arbor 241
Singapore 225
Princeton 220
San Diego 210
Sofia 195
New York 154
Modena 152
Beijing 106
London 96
Helsinki 76
Dublin 70
Jakarta 53
Dearborn 49
Rome 43
Izmir 41
Eugene 39
Edinburgh 35
Shanghai 34
Milan 33
Norwalk 33
Kilburn 21
Southwark 21
Parma 20
Chicago 19
Redwood City 19
San Jose 19
Bologna 17
Stockholm 17
Hounslow 15
Jacksonville 15
Dong Ket 14
Prescot 14
Tokyo 14
Vienna 14
Amsterdam 13
Brussels 13
Madrid 13
Paris 13
Lappeenranta 12
Wuhan 12
Boardman 11
Chiswick 11
Frankfurt am Main 11
Belgrade 10
Dallas 9
Liebefeld 9
Atlanta 8
Brentwood 8
Budapest 8
Catania 8
Grafing 8
Istanbul 8
Montreal 8
Munich 8
Ottawa 8
Reggio Emilia 8
Taipei 8
Bremen 7
Guangzhou 7
Los Angeles 7
Naples 7
Pontedera 7
Toronto 7
Zagreb 7
Hyderabad 6
Johannesburg 6
Milwaukee 6
Palermo 6
Prague 6
Sydney 6
Acton 5
Bari 5
Brno 5
Kuala Lumpur 5
Padova 5
Priverno 5
Pune 5
San Francisco 5
São Bernardo do Campo 5
São Paulo 5
Zurich 5
Berlin 4
Bolzano 4
Bucharest 4
Carpi 4
Cesena 4
Chennai 4
Copenhagen 4
Florence 4
Totale 10.757
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 193
Stamina therapies: Let the record stand 190
Nutraceuticals: opening the debate for a regulatory framework 189
Association of neovascular age-related macular degeneration with month and season of birth in Italy 167
Adherence to selective serotonin and serotonin-norepinephrine reuptake inhibitor prescriptions affects overall medication adherence in older persons: Evidence from the Italian nationwide osmed health-db database 166
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 157
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 149
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience 145
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 144
Safety and Efficacy of Red Yeast Rice Phytocomplex and Lovastatin: a Comparative Analysis 141
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 138
A case-control study of visually evoked postural responses in childhood with primary headaches 137
Take This Cognitive Training Efficacy Bar Fight Outside (to a Regulatory Agency) 136
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways 132
Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy 131
Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans 126
1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice 118
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research 117
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 116
Steps forward in regulatory pathways for acute and chronic heart failure 114
The endless frontier? The recent increase of R&D productivity in pharmaceuticals 110
Approaches to attenuated psychosis syndrome treatments: A perspective on the regulatory issues 102
Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice 98
Digital Phenotyping and Dynamic Monitoring of Adolescents Treated for Cancer to Guide Intervention: Embracing a New Era 98
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats 96
Balancing access to medicines and sustainability in Europe: An analysis from the network of competent authorities on pricing and reimbursement (CAPR) 95
In vitro evidence for the presence of [ 3H]-haloperidol uptake in rat brain 93
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 91
Impact of reimbursement limits on patient access to direct-acting antivirals in Italy: Analysis of data from national registries 90
Identification and validation of biomarkers for autism spectrum disorders 89
Environmental enrichment influences mouse hippocampal neuroinflammatory response 88
Antinociceptive activity of Δ9-tetrahydrocannabinol non-ionic microemulsions 88
Scaling up health knowledge at European level requires sharing integrated data: An approach for collection of database specification 85
Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression 85
Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic 84
Generic and biosilimilar medicines use and expenditure: A report from the National Observatory on the Use of Medicines (OsMed) of the Italian Medicines Agency (AIFA) 82
Sleep deprivation in the rat: an animal model of mania 82
Kounis Syndrome: An analysis of spontaneous reports from international pharmacovigilance database 81
Clinical trials and late-stage drug development for Alzheimer's disease: An appraisal from 1984 to 2014 81
Immunocytochemical study of the forebrain serotonergic innervation in Sardinian alcohol-preferring rats 80
Practical issues with amisulpride in the management of patients with schizophrenia 80
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry 80
Use and reimbursement of off-label drugs in pediatric anesthesia: The Italian experience 80
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis 80
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2′, 4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7] cyclohepta[1,2-c]pyrazole-3-carboxamide 80
Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration 79
Monitoring registries at Italian medicines agency: Fostering access, guaranteeing sustainability 78
Regulatory evaluation of Glybera in Europe-two committees, one mission 78
Disclosure of grounds of European withdrawn and refused applications: A step forward on regulatory transparency 78
Kounis syndrome due to antibiotics: A global overview from pharmacovigilance databases 77
Effectiveness and cost effectiveness of bevacizumab in metastatic colorectal cancer 77
Validated method to determine quetiapine and norquetiapine in microsomal matrix by LC MS-MS: Implication in quetiapine metabolism 77
Managed entry agreements 77
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency 76
ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action 76
High prevalence of poor quality drug prescribing in older individuals: A nationwide report from the Italian Medicines Agency (AIFA) 76
Circulating levels of anticonvulsant metabolites of progesterone in women with partial epilepsy in the intercritical phase 76
Haloperidol, but not clozapine, produces dramatic catalepsy in Δ 9-THC-treated rats: Possible clinical implications 75
Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia 75
Clinical implications of dopamine research in schizophrenia 75
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 75
Synthesis and in vitro evaluation of trifluoroethylamine analogues of enkephalins 74
The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex 74
Is HCMV vaccine an unmet need? The state of art of vaccine development 74
Evolutionary psychopharmacology, mental disorders, and ethical behavior 73
DSM-5 and clinical trials in psychiatry: Challenges to come? 73
Contrasting effects of diazepam and repeated restraint stress on latent inhibition in mice 72
Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review 72
Tricyclic pyrazoles. Part 5. novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 ligands using molecular hybridization based on scaffold hopping 71
Consensus on the use of substituted benzamides in psychiatric patients 71
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 71
Novel epigenetic target therapy for prostate cancer: A preclinical study 70
The future is now: Model-based clinical trial design for Alzheimer's disease 70
Dysbindin, D3 receptors, and their genetic interaction differently regulate neuroplasticity genes in the mouse brain 69
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 69
Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: Implications for the antiglaucoma properties of marihuana 69
Transparency in medical research: Time for a paradigm shift 68
Subthreshold depression in older subjects: An unmet therapeutic need 68
Alternative pricing strategies for cancer drugs 67
Rare diseases and effective treatments: Are we delivering? 66
Biosimilars: The paradox of sharing the same pharmacological action without full chemical identity 66
The European Medicines Agency's strategies to meet the challenges of Alzheimer disease 65
Insights Into the Decision Making of Advisory Groups to the Italian Medicines Agency 65
Building a virtual archive using brain architecture and Web 3D to deliver neuropsychopharmacology content over the Internet 65
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 65
Farmaci antidepressivi parte II: SNRI e farmaci multimodali 64
The placebo arm in clinical studies for treatment of Psychiatric Disorders: A Regulatory Dilemma 64
Are we ready? What is missing and what is needed? A regulator's perspective 63
Reflections on decisions made on the well-established use of medicinal products by EU regulators and the ECJ 63
Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients 63
Transparency in medical research: Time for a paradigm shift 62
(-)S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors 62
Are "social drugs" (tobacco, coffee and chocolate) related to the bipolar spectrum? 62
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 62
The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex 61
Nimodipine inhibits cocaine-induced dopamine release and motor stimulation 61
The effects of novel and newly approved antipsychotics on serum prolactin levels: A comprehensive review 60
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease 59
Brain dialysis provides evidence for D2-dopamine receptors modulating noradrenaline release in the rat frontal cortex 59
Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent 59
Totale 8.920
Categoria #
all - tutte 99.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020655 0 0 7 35 40 87 140 60 59 51 147 29
2020/20214.699 116 54 87 1.617 709 339 103 537 84 573 213 267
2021/20222.849 132 283 70 98 70 180 162 105 369 345 730 305
2022/20233.065 321 160 162 245 320 446 44 479 449 54 303 82
2023/20242.038 128 146 121 197 383 136 79 264 77 59 91 357
2024/2025246 139 55 52 0 0 0 0 0 0 0 0 0
Totale 13.869